Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention

Published:2015-08 Issue:8 Volume:31 Page:989-997
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Li Yi,Yang Daya,Lu Lihe,Wu Dexi,Yao Jianping,Hu Xun,Long Ming,Luo Chufan,Du Zhimin

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Profile of chronic and recurrent angina pectoris in a referral population;Alexander;Am J Cardiol,2008

2. Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry;Venkitachalam;Circ Cardiovasc Qual Outcomes,2009

3. Postprocedure chest pain after coronary stenting: implications on clinical restenosis;Kini;J Am Coll Cardiol,2003

4. Recurrent angina after revascularization: an emerging problem for the clinician;Lemos;Coron Artery Dis,2004

5. Recurrent angina after coronary revascularization: a clinical challenge;Abbate;Eur Heart J,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Microvascular Resistance Reserve Measured Immediately After PCI in Stable Coronary Artery Disease;Circulation: Cardiovascular Interventions;2024-06

2. Coronary Microvascular Dysfunction in Women;Current Cardiovascular Risk Reports;2024-06

3. Coronary microvascular dysfunction: A review of recent progress and clinical implications;Frontiers in Cardiovascular Medicine;2023-01-26

4. Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization;Current Cardiology Reports;2022-10-26

5. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA;Cardiovascular Drugs and Therapy;2021-11-12